Hepatic Ischemia-reperfusion Injury

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hepatic Ischemia-reperfusion Injury trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06895798

Differential Impact of Pringle and Portal Vein Occlusion on Myocardial Injury After Non-Cardiac Surgeries.

This study aims to investigate the impact of hepatic ischemia-reperfusion injury (HIRI) on the incidence of myocardial injury after non-cardiac surgery (MINS) a…

China800 participantsStarted 2023-01-04

All recent trials (23 shown)

CompletedNot Applicable

NCT07362745

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

The goal of this observational study is to understand why liver transplants from donors with fatty liver disease (steatotic donor livers) are more vulnerable to…

China300 participantsStarted 2015-01-01

Active — Not RecruitingPhase 4

NCT05031026

Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfun…

the aim of the study is to approve the hypothesis that dexmedetomidine can protect against glycocalyx degradation induced by hepatic ischemia-reperfusion injury…

Egypt60 participantsStarted 2022-03-15

Treatment: Dexmedetomidine, Normal Saline

Hepatic Ischemia-reperfusion Injury

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Differential Impact of Pringle and Portal Vein Occlusion on Myocardial Injury After Non-Cardiac Surgeries.

All recent trials (23 shown)

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfun…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Differential Impact of Pringle and Portal Vein Occlusion on Myocardial Injury After Non-Cardiac Surgeries.

All recent trials (23 shown)

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfun…

Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLD

Liver Ischemia-reperfusion Injury and Clinical Data Analysis

Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome

Indocyanine Green Clearance Test in Liver Transplantation (LivInG)

Liver Protection of RIPC in Pediatric Living Donor Liver Transplantation

Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation

Donor Simvastatin Treatment in Organ Transplantation

Purge Vs no Purge in Living Donor Liver Transplantation Recipients

Intermittent Portal and Graft Purge in Living Donor Liver Transplantation

Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC

Reperfusion-induced Self-antigen Excretion Following Major Liver Surgery

Hypothermic Perfusion During Hemihepatectomy

Antinociceptive Modalities on Ischemia Reperfusion Injury

Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy

Methylprednisolone N Acetylcysteine in Hepatic Resections

Use of N-Acetylcysteine During Liver Procurement

N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection